Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation
- PMID: 11223974
- DOI: 10.1038/sj.bmt.1702716
Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation
Abstract
We conducted a retrospective review of the clinical features and outcome of adenovirus infection in 572 consecutive patients transplanted in a single centre over a 10 year period. One hundred patients (17%) had a total of 105 episodes of adenovirus infection diagnosed at a median of 18 days post transplant (range 2-150 days). The incidence was higher in children than adults (21% vs 9%, P < 0.001) and in unrelated donor vs matched sibling donor transplants (26% vs 9%, P < 0.001). Diarrhoea and fever were the most common presenting features. Reflecting these symptoms, the most common site of isolation was the stool. Serotypes 1, 2 and 7 were the most frequently seen (total of 41/68 or 60% of evaluable cases). In six patients (6%) adenovirus infection was the direct cause of death occurring at a median of 72 days post transplant (range 18-365 days). Five of these six patients had pulmonary involvement and four had associated graft-versus-host disease (GVHD). Three further patients were considered to have severe adenoviral disease (total incidence 9%). Isolation of virus from multiple sites correlated with a poor outcome (P < 0.001). Comorbid viral infection was common in this group with 50% of all patients having other viruses isolated (predominantly polyoma virus and cytomegalovirus). We conclude that adenovirus is commonly isolated after bone marrow transplant and is a cause of significant morbidity but was a rare cause of mortality (6/572 = 1%) in our patient group as a whole. The relative infrequency of severe infection will make it difficult for the transplant physician to decide which patients should receive experimental antiviral drugs such as ribavirin and cidofovir or immunomodulatory therapy with donor white cell infusions.
Similar articles
-
Adenoviral infection after allogeneic stem cell transplantation (SCT): report on 130 patients from a single SCT unit involved in a prospective multi center surveillance study.Bone Marrow Transplant. 2001 Jul;28(1):51-7. doi: 10.1038/sj.bmt.1703083. Bone Marrow Transplant. 2001. PMID: 11498744 Clinical Trial.
-
Outcome of children requiring admission to an intensive care unit after bone marrow transplantation.Crit Care Med. 2003 May;31(5):1299-305. doi: 10.1097/01.CCM.0000060011.88230.C8. Crit Care Med. 2003. PMID: 12771594
-
Time of onset, viral load, relapse, and duration of active cytomegalovirus infection in bone marrow transplant outcomes.Exp Clin Transplant. 2008 Mar;6(1):67-73. Exp Clin Transplant. 2008. PMID: 18405248
-
Adenovirus infection after pediatric bone marrow transplantation.Bone Marrow Transplant. 1999 Feb;23(3):277-82. doi: 10.1038/sj.bmt.1701563. Bone Marrow Transplant. 1999. PMID: 10084260 Review.
-
Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.Dan Med Bull. 2007 May;54(2):112-39. Dan Med Bull. 2007. PMID: 17521527 Review.
Cited by
-
Broad-range PCR-electrospray ionization mass spectrometry for detection and typing of adenovirus and other opportunistic viruses in stem cell transplant patients.J Clin Microbiol. 2013 Dec;51(12):4186-92. doi: 10.1128/JCM.01978-13. Epub 2013 Oct 9. J Clin Microbiol. 2013. PMID: 24108617 Free PMC article.
-
Adenovirus: current epidemiology and emerging approaches to prevention and treatment.Curr Infect Dis Rep. 2014 Aug;16(8):416. doi: 10.1007/s11908-014-0416-y. Curr Infect Dis Rep. 2014. PMID: 24908344
-
Molecular diagnosis and management of viral infections in hematopoietic stem cell transplant recipients.Mol Diagn Ther. 2012 Apr 1;16(2):63-77. doi: 10.1007/BF03256431. Mol Diagn Ther. 2012. PMID: 22497528 Review.
-
Emergent strain of human adenovirus endemic in Iowa.Emerg Infect Dis. 2005 Jan;11(1):127-8. doi: 10.3201/eid1101.040490. Emerg Infect Dis. 2005. PMID: 15705336 Free PMC article.
-
Human cord blood-derived viral pathogens as the potential threats to the hematopoietic stem cell transplantation safety: A mini review.World J Stem Cells. 2019 Feb 26;11(2):73-83. doi: 10.4252/wjsc.v11.i2.73. World J Stem Cells. 2019. PMID: 30842806 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical